The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...

Recordati Rare Diseases Inc. today announced the presentation of real-world data that build upon the safety data of sutimlimab, an FDA-approved therapy for hemolysis in adults with cold agglutinin ...

Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand ...

Summary • Omeros Corporation’s stock jumped 72.1% to $15.06 following FDA approval of Yartemlea, its therapy for TA-TMA.• Yartemlea is the first therapy targeting hematopoietic stem cell ...

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells ...

The new grading structure under the Competency-Based Education (CBE) system is going to reshape how learners transitioning to Senior School will be assessed and placed. The system, built on cumulative ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

When Martha Hall Findlay heard Canada’s prime minister and Alberta’s premier speak with enthusiasm Thursday about the necessity of the Pathways carbon capture project to their long-promised “grand ...

Vikings Hilmir Rafn Mikaelsson attempts a shot on goal during the match against FK Eik Tonsberg NTB, NTB / Alamy / Profimedia Eight years after being just days away from filing for bankruptcy, ...